Michael R. Hamblin

University of Johannesburg, Iran University of Medical Sciences

Papers

Total Citations

124

H-Index

About

Michael R. Hamblin is a pioneering figure at the intersection of photomedicine, nanotechnology, and drug delivery, whose work has fundamentally shaped the development of light-based therapies and advanced biomaterials. His research spans the design of bioinspired hydrogels that bridge laboratory innovation and clinical application, as well as the use of artificial intelligence to engineer nanovectors for gene therapy and mRNA vaccines—a forward-looking contribution that has garnered 66 citations since 2022. Hamblin’s major contributions include elucidating the mechanisms of photodynamic therapy and low-level light therapy, and translating these insights into practical antimicrobial and wound-healing treatments. With over 600 published papers and an h-index exceeding 100, his work has been cited more than 50,000 times, reflecting its profound impact on fields ranging from oncology to regenerative medicine. Notably, his 2021 paper on bioinspired hydrogels (58 citations) exemplifies his ability to merge materials science with clinical needs, creating “smart” scaffolds that respond to biological cues. A prolific inventor and editor, Hamblin’s legacy lies in his relentless pursuit of therapies that harness light and biomimicry to solve pressing medical challenges, inspiring a new generation of interdisciplinary researchers.